Coronial
QLDhospital

Stimpson, Reginald - Non-inquest findings

Deceased

Reginald Stimpson

Demographics

73y, male

Coroner

Clements

Date of death

2015-03-27

Finding date

2017-07-18

Cause of death

Acute intracranial haemorrhage, due to or as a consequence of coagulopathy, due to or as a consequence of pulmonary embolism (anticoagulant therapy), due to or as a consequence of deep vein thrombosis, due to or as a consequence of osteoarthritis (elective total knee replacement)

AI-generated summary

Mr Stimpson, a 73-year-old man, died from massive intracerebral haemorrhage secondary to coagulopathy caused by inadvertent double administration of anticoagulants (Clexane and Xarelto). He developed bilateral pulmonary emboli post-operatively after total knee replacement and was appropriately commenced on therapeutic anticoagulation with Clexane. When transitioning to oral Xarelto, the prescribing physician documented the change in progress notes but failed to properly cancel Clexane on the medication chart. Nursing staff administering medications lacked education about Xarelto and were unaware that dual anticoagulation was contraindicated. They received the medication twice (evening of 26 March and morning of 27 March) before the error was discovered. Critical failures included: inadequate medication chart cancellation procedures, split nursing responsibilities, lack of staff education on novel anticoagulants, poor handover communication, and absence of systematic checks for drug interactions. The hospital implemented extensive remedial actions including new medication safety policies, staff education, revised medication charts separating anticoagulants, and cognitive screening tools.

AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.

Specialties

orthopaedic surgerygeneral medicineintensive care

Error types

medicationcommunicationsystemdelay

Drugs involved

enoxaparinrivaroxabanaspirinheparin

Clinical conditions

osteoarthritisdeep vein thrombosispulmonary embolismpost-operative complicationcoagulopathyintracerebral haemorrhagesubdural haemorrhageAlzheimer's dementiadeliriumhyperthyroidismurinary retentionlower lobe pneumoniahypoxia

Procedures

total knee replacementspinal anaesthetic

Contributing factors

  • Medication error: dual anticoagulation (Clexane and Xarelto) administered inadvertently
  • Failure to properly cancel Clexane on medication chart when transitioning to Xarelto
  • Inadequate nursing staff education on novel anticoagulants (Xarelto)
  • Poor communication and handover between medical and nursing staff
  • Split nursing responsibilities for oral versus subcutaneous medication administration
  • Nursing staff unaware that Clexane and Xarelto should not be given together
  • Lack of systematic checks for drug interactions and duplicate therapy
  • Two separate medication charts for anticoagulants contributed to oversight
  • Assumption-based practice: NUM assumed physician had cancelled Clexane; RN assumed overlapping was permitted as with Clexane-Warfarin
  • Insufficient initial post-operative anticoagulation prophylaxis (aspirin only prescribed)
  • Inadequate escalation of care when patient showed signs of deterioration on 20-25 March
  • Patient discharged from ICU prematurely despite ongoing hypoxia and tachycardia
  • Lack of post-operative complication clinical pathway

Coroner's recommendations

  1. Physician group to review clinician handover and documentation processes; develop Medical Consultation handover form
  2. Implement nursing staff education sessions on novel anticoagulants hospital-wide
  3. Revise nursing medication competency to include novel anticoagulant-related questions
  4. Nursing staff involved in medication errors to complete NPS medication safety package online
  5. Include 'checking when two drugs with same indication prescribed' in Traffic Light Medication Safety System
  6. Review inpatient medication chart and consolidate anticoagulant orders; separate chart into anticoagulants/antiplatelet and heparin infusion sections
  7. Introduce process where one nurse completes full medication round and administers all drugs for allocated patients
  8. Develop and implement Cognitive Impairment risk assessment tool with family notification triggers
  9. Review and develop surgical post-operative complication clinical pathway with appropriate monitoring
  10. Educate nursing staff on regular observation of vital signs overnight with escalation via MET call when applicable
  11. Implement process where high risk drugs, including anticoagulants, are not stored as extra stock on wards
  12. ICU to review step-down/discharge criteria for unwell patients no longer requiring ICU-level care
  13. Pharmacy to review process for high risk drug education
  14. Review VTE risk assessment tool to include surgical high risk factors while complying with NHMRC guidelines
  15. Review and implement High Risk Medication Policy and communicate to all nursing staff
  16. Communicate correct process for cancelling medications to all visiting medical officers with visual examples
Full text

Source and disclaimer

This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.

Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.

Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.